In the lawsuit, Mr. Shapiro claims the drugmaker misled physicians in the state about its drug by downplaying its addiction risk and saying there was no maximum dose. Additionally, the suit said the drugmaker made more sales visits in Pennsylvania than any other state except California.
“Simply stated, Purdue [Pharma] took advantage of addiction to make money,” the lawsuit reads, according to the report.
Purdue Pharma faces similar accusations in lawsuits filed by more than three dozen states and 1,600 U.S. cities.
More articles on pharmacy:
8 recent pharmaceutical lawsuits, settlements
McKesson renews distribution deal with CVS Health
Sacklers discussed selling Purdue Pharma in 2000, court documents reveal
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
